Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  cardiovascular complications
Trial Type:  Supportive care
Trial Status:  Closed
Sponsor of Trial:  NCI
Results 1-25 of 25 for your search:
Start Over
Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 0 to 21
Sponsor: NCI, Other
Protocol IDs: 9404, U10CA030969, POG-9404, CDR0000064664, NCT01230983
Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI, Other
Protocol IDs: 9426, POG-9426, CCG-P9426, CDR0000065013, COG-9426, NCT00002827
Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI, Other
Protocol IDs: 9425, COG-9425, CDR0000065359, P9425, POG-9425, NCT00005578
Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 8 to 120
Sponsor: NCI, Other
Protocol IDs: P9480, POG-9480, NCI-P97-0086, CDR0000065745, NCT00003070
Combination Chemotherapy and Radiation Therapy in Treating Children With Acute Lymphoblastic Leukemia
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 1 to 17
Sponsor: NCI, Other
Protocol IDs: CDR0000066202, DFCI-95001, DFCI-FDR001197, NCI-G99-1651, NCT00004034
Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02792, CALGB-9840, U10CA031946, CLB-9840, NCT00003440
Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 30 and under
Sponsor: NCI, Other
Protocol IDs: P9754, COG-P9754, POG-P9754, CCG-P9754, CDR0000067129, NCT00003937
Phase III Pilot Randomized Study of Filgrastim-SD/01 Versus Filgrastim (G-CSF) With Concurrent Chemotherapy in Patients With Newly Diagnosed Sarcoma (Closed to Accrual as of 5/26/2009)
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 25 and under at diagnosis
Sponsor: NCI
Protocol IDs: NCI-00-C-0092, AMGEN-20000124, NCT00020137
Phase III Randomized Trial of FAC (5-FU/ADR/CTX) with vs without ICRF-187 for Cardioprotection in Patients with Advanced Breast Cancer
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: DUT-BR-1, NCI-T85-0009Q, T85-0009
Phase III Randomized Study of ICRF-187 Cardioprotection in Patients Treated with ADR for Pediatric Sarcomas
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 25 and under
Sponsor: NCI
Protocol IDs: NCI-89-C-07, NCI-T88-0200N, T88-0200
Phase III Study of High-Dose CTX plus GM-CSF with vs without WR-2721 Chemoprotection in Patients with Advanced Malignancies
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CLB-9160, CALGB-9160
SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 16 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000077691, U10CA032102, SWOG-9133, CLB-9391, NCT00002495
Phase II Study of High-Dose Doxorubicin with Dexrazoxane Cardioprotection and GM-CSF for Advanced Malignant Mesothelioma (Summary Last Modified 09/97)
Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: any age
Sponsor: NCI
Protocol IDs: CLB-9631, CALGB-9631
Combination Chemotherapy Before and After Surgery in Treating Patients With Osteosarcoma
Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: 25 and under
Sponsor: NCI
Protocol IDs: CDR0000067263, NCI-99-C-0125I, NCT00019864
Phase I Study of Paclitaxel plus Doxorubicin/Dexrazoxane with and without Growth Factor Support in Women with Advanced Breast Cancer (Summary Last Modified 04/2000)
Phase: Phase I
Type: Supportive care, Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: AECM-119951142, NCI-T95-0054O, T95-0054
Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors
Phase: Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 1 to 21
Sponsor: NCI
Protocol IDs: NCI-2012-01872, ADVL0211, U01CA097452, CDR0000069387, COG-ADVL0211, NCI-03-C-0202, NCT00039481
Phase I Study of ICRF-187 Pretreatment for Protection Against Doxorubicin Cardiotoxicity
Phase: Phase I
Type: Supportive care
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: OSU-83HO096, NCI-T83-1050W
Phase I Study of Doxorubicin with ICRF-187 Cardioprotection plus GM-CSF in Patients with Advanced Solid Tumors
Phase: Phase I
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NYU-T89-0049, NCI-T89-0049D, T89-0049
Phase I Trial of High-Dose DOX plus Recombinant GM-CSF plus ADR-529 in Patients with Solid Tumors
Phase: Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CLB-8983, CALGB-8983
Phase I Pilot Study of High-Dose DOX Given with G-CSF and ADR-529 in the Adjuvant Treatment of Patients with Hepatocellular Carcinoma Who Have Undergone Hepatectomy and Orthotopic Liver Transplantation
Phase: Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MTS-91414-NPD, NCI-T91-0234O, T91-0234
SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000065237, U10CA032102, SWOG-9342, NCT00002900
Study of Metabolic Syndrome in Adolescent and Young Adult Survivors of Childhood Leukemia Who Have Undergone Stem Cell Transplant
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: 11 and over
Sponsor: NCI, Other
Protocol IDs: IR 7141, P30CA077598, UMN-2003NT063, CDR0000642276, IR-6980, FHCRC-2357.00, 2003NT063, NCT00920842
Vascular and Cognitive Assessments in Patients With Breast Cancer Undergoing Chemotherapy After Surgery
Phase: No phase specified
Type: Diagnostic, Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CCCWFU 74111, NCI-2011-02361, NCT01483196
Start Over